Repligen (RGEN) Tops Q3 EPS by 4c ; Offers Guidance

Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.46, $0.04 better than the analyst estimate of $0.42. Revenue for the quarter came in at $189 million versus the consensus estimate of $181.78 million.

GUIDANCE:

Repligen sees FY2025 EPS of $1.65-$1.68, versus the consensus of $1.69. Repligen sees FY2025 revenue of $729-737 million, versus the consensus of $727.8 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.

You May Also Be Interested In

• Casey's General Stores (CASY) Tops Q1 EPS by 69c
• Smithfield Foods cuts Q3 outlook on fresh pork and hog price pressure
• ABM Industries (ABM) Reports In-Line Q3 EPS; raises guidance